Johnson & Johnson said Tuesday it has started human testing of an experimental Ebola vaccine in Europe.
The phase-I clinical trial of the vaccine, under development at its Janssen Pharmaceutical Companies division, is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Pediatrics.
Phase-I studies test the safety of a product in healthy volunteers.
For more business news, head to PBJ.com
Copyright bizjournal
